PL375487A1 - Miejscowe leczenie chorób skóry - Google Patents
Miejscowe leczenie chorób skóryInfo
- Publication number
- PL375487A1 PL375487A1 PL03375487A PL37548703A PL375487A1 PL 375487 A1 PL375487 A1 PL 375487A1 PL 03375487 A PL03375487 A PL 03375487A PL 37548703 A PL37548703 A PL 37548703A PL 375487 A1 PL375487 A1 PL 375487A1
- Authority
- PL
- Poland
- Prior art keywords
- skin diseases
- topical treatment
- topical
- treatment
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39522102P | 2002-07-11 | 2002-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL375487A1 true PL375487A1 (pl) | 2005-11-28 |
Family
ID=30115840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL03375487A PL375487A1 (pl) | 2002-07-11 | 2003-07-10 | Miejscowe leczenie chorób skóry |
Country Status (20)
Country | Link |
---|---|
US (1) | US20040038958A1 (pl) |
EP (1) | EP1531818A1 (pl) |
JP (1) | JP2005537262A (pl) |
KR (1) | KR20050021464A (pl) |
CN (1) | CN1681500A (pl) |
AR (1) | AR040647A1 (pl) |
AU (1) | AU2003254332B2 (pl) |
BR (1) | BR0312696A (pl) |
CA (1) | CA2492093A1 (pl) |
HR (1) | HRP20050133A2 (pl) |
IL (1) | IL166016A0 (pl) |
MX (1) | MXPA05000486A (pl) |
NO (1) | NO20050718L (pl) |
NZ (1) | NZ537482A (pl) |
PL (1) | PL375487A1 (pl) |
RU (1) | RU2005103608A (pl) |
TW (1) | TW200410690A (pl) |
UA (1) | UA80711C2 (pl) |
WO (1) | WO2004006920A1 (pl) |
ZA (1) | ZA200500108B (pl) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7393960B2 (en) | 2002-08-29 | 2008-07-01 | Merck & Co., Inc. | Indoles having anti-diabetic activity |
WO2004020408A1 (en) | 2002-08-29 | 2004-03-11 | Merck & Co., Inc. | Indoles having anti-diabetic activity |
WO2004107678A2 (en) * | 2003-05-28 | 2004-12-09 | Artimi Ltd | Ultra-wideband network, device, device controller, method and data packet for establishing a mesh network and forwarding packets on another channel |
PT1713471E (pt) * | 2004-02-06 | 2012-04-10 | Meda Pharma Gmbh & Co Kg | Combinação de anticolinérgicos e inibidores de fosfodiesterase tipo 4 para o tratamento de doenças respiratórias |
SI1713473T1 (sl) * | 2004-02-06 | 2013-06-28 | Meda Pharma Gmbh & Co. Kg | Kombinacija antiholinergikov in glukokortikoidov za dolgotranjno zdravljenje astme in KOPB |
JP4961131B2 (ja) * | 2004-10-29 | 2012-06-27 | 田辺三菱製薬株式会社 | 皮膚損傷治療剤 |
TWI339578B (en) | 2004-10-29 | 2011-04-01 | Mitsubishi Tanabe Pharma Corp | Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
CA2595791C (en) * | 2005-03-16 | 2013-10-08 | Meda Pharma Gmbh & Co. Kg | The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases |
NZ591969A (en) | 2005-12-21 | 2012-05-25 | Meda Pharma Gmbh & Co Kg | Combination of anticholinergics, glucocorticoids, beta2-adrenoceptor agonists, PDE 4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
JP2009523734A (ja) * | 2006-01-13 | 2009-06-25 | ワイス | 5−ヒドロキシトリプタミン受容体のためのリガンドとしてのスルホニル置換された1h−インドール |
AU2007218725B2 (en) | 2006-02-21 | 2011-12-01 | Eisai R & D Management Co., Ltd. | 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative |
WO2008099887A1 (ja) | 2007-02-16 | 2008-08-21 | Eisai R & D Management Co., Ltd. | メチル n-[3-(6,7-ジメトキシ-2-メチルアミノキナゾリン-4-イル)フェニル]テレフタラミックアシッドの結晶、非晶質体または塩 |
ATE538102T1 (de) | 2007-08-17 | 2012-01-15 | Eisai R&D Man Co Ltd | Verfahren zur herstellung eines chinazolinderivats |
CN101687819B (zh) | 2007-08-17 | 2013-03-20 | 卫材R&D管理有限公司 | 外用剂 |
JOP20130213B1 (ar) | 2012-07-17 | 2021-08-17 | Takeda Pharmaceuticals Co | معارضات لمستقبلht3-5 |
PL3201203T3 (pl) | 2014-09-29 | 2021-11-22 | Takeda Pharmaceutical Company Limited | Krystaliczna postać 1-(1-metylo-1h-pirazol-4-ilo)-n-((1r,5s,7s)-9-metylo-3-oksa-9-azabicyklo[3.3.1]nonan-7-ylo)-1h-indolo-3-karboksyamidu |
CN108602775B (zh) | 2016-01-14 | 2022-04-29 | 贝思以色列女会吏医学中心公司 | 肥大细胞调节剂及其用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4341783A (en) * | 1980-07-31 | 1982-07-27 | Lemmon Company | Topical use of dyphylline and dyphylline containing compositions |
WO1994024984A2 (en) * | 1993-04-30 | 1994-11-10 | Winget Rodner R | Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto |
EP1076657B1 (de) * | 1998-04-28 | 2004-08-04 | elbion AG | Neue hydroxyindole, deren verwendung als inhibitoren der phosphodiesterase 4 und verfahren zu deren herstellung |
-
2003
- 2003-07-01 US US10/611,649 patent/US20040038958A1/en not_active Abandoned
- 2003-07-09 TW TW092118759A patent/TW200410690A/zh unknown
- 2003-07-10 PL PL03375487A patent/PL375487A1/pl unknown
- 2003-07-10 CA CA002492093A patent/CA2492093A1/en not_active Abandoned
- 2003-07-10 NZ NZ537482A patent/NZ537482A/en unknown
- 2003-07-10 AU AU2003254332A patent/AU2003254332B2/en not_active Ceased
- 2003-07-10 RU RU2005103608/04A patent/RU2005103608A/ru not_active Application Discontinuation
- 2003-07-10 MX MXPA05000486A patent/MXPA05000486A/es active IP Right Grant
- 2003-07-10 BR BR0312696-0A patent/BR0312696A/pt not_active IP Right Cessation
- 2003-07-10 AR AR20030102493A patent/AR040647A1/es not_active Application Discontinuation
- 2003-07-10 JP JP2004520586A patent/JP2005537262A/ja not_active Withdrawn
- 2003-07-10 EP EP03763810A patent/EP1531818A1/en not_active Withdrawn
- 2003-07-10 CN CNA038215209A patent/CN1681500A/zh active Pending
- 2003-07-10 WO PCT/EP2003/007514 patent/WO2004006920A1/en active Application Filing
- 2003-07-10 KR KR10-2005-7000572A patent/KR20050021464A/ko not_active Application Discontinuation
- 2003-10-07 UA UAA200500163A patent/UA80711C2/uk unknown
-
2004
- 2004-12-28 IL IL16601604A patent/IL166016A0/xx unknown
-
2005
- 2005-01-06 ZA ZA200500108A patent/ZA200500108B/en unknown
- 2005-02-10 NO NO20050718A patent/NO20050718L/no not_active Application Discontinuation
- 2005-02-11 HR HR20050133A patent/HRP20050133A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003254332A1 (en) | 2004-02-02 |
RU2005103608A (ru) | 2005-06-27 |
ZA200500108B (en) | 2005-02-23 |
CA2492093A1 (en) | 2004-01-22 |
KR20050021464A (ko) | 2005-03-07 |
UA80711C2 (en) | 2007-10-25 |
JP2005537262A (ja) | 2005-12-08 |
US20040038958A1 (en) | 2004-02-26 |
AR040647A1 (es) | 2005-04-13 |
TW200410690A (en) | 2004-07-01 |
NZ537482A (en) | 2006-09-29 |
BR0312696A (pt) | 2005-04-26 |
WO2004006920A1 (en) | 2004-01-22 |
MXPA05000486A (es) | 2005-07-22 |
IL166016A0 (en) | 2006-01-15 |
CN1681500A (zh) | 2005-10-12 |
NO20050718L (no) | 2005-04-01 |
AU2003254332B2 (en) | 2009-01-08 |
HRP20050133A2 (en) | 2005-04-30 |
EP1531818A1 (en) | 2005-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003239568A1 (en) | Pyrrolotriazinone compounds and their use to treat diseases | |
GB0612417D0 (en) | Compositions and methods for topical treatment of skin infection | |
AU2003278775A8 (en) | Porifera-based therapeutic compositions for treating and preventing skin diseases | |
AU2003265225A8 (en) | Preparations for topical skin use and treatment | |
AU2003286567A8 (en) | Methods for the treatment of skin disorders | |
IL169338A0 (en) | Therapeutic formulations for the treatment of beta-amyloid related diseases | |
GB0201850D0 (en) | Therapeutic treatment | |
EP1727530A4 (en) | TOPICAL FORMULATIONS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS | |
ZA200707934B (en) | Thereapeutic formulations for the treatment of beta-amyloid related diseases | |
HK1083062A1 (en) | Treatment of diseases and conditions mediated by increased phosphorylation | |
IL166016A0 (en) | Topical treatment of skin diseases | |
IL165394A0 (en) | Use of thio-oxindole derivatives in treatment of skin disorders | |
AUPQ877300A0 (en) | Topical treatment of skin | |
EP1636160A4 (en) | NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER, METABOLISM AND SKIN DISEASES | |
EP1560572A4 (en) | TOPICAL PEST FORMULATIONS AND METHODS OF TREATMENT | |
EP1648399A4 (en) | METHOD AND TOPIC COMPOSITION FOR TREATING SKIN HYPERPIGMENTATION | |
GB0211295D0 (en) | Treatment of pain | |
AU2003251407A8 (en) | Topical treatment for skin irritation | |
AU2003256447A1 (en) | Treatment of autoimmune skin diseases | |
AU2002352566A1 (en) | Use of corrinoids in the treatment of skin diseases | |
GB0101146D0 (en) | Treatment of skin conditions | |
AU2003297570A1 (en) | Treatment of skin diseases | |
AU2003237742A1 (en) | Composition for the treatment of skin diseases and for improving hair growth | |
AU2002365654A8 (en) | Treatment of diseases via the skin | |
GB0208183D0 (en) | Treatment of skin conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |